Expression of DDP10 was not significantly correlated with blood cells counts or overall survival time in patients with RAEB.
RAEB患者总生存时间及外周血细胞数量与外周血ddp10表达量无显著相关性。
Primary efficacy endpoints were overall survival and time to symptomatic progression.
主要效果终端指标为总生存率和症状进展时间。
Results: the overall 5-year survival of the patients was 82.0% and the median survival time was 100.0 months.
结果:本组盆腔淋巴结阴性患者的五年总体生存率为82 0 %,中位生存时间10 0 0月。
应用推荐